Head of Health Data Science Centre appointed
Emanuele Di Angelantonio, clinician, epidemiologist and medical statistician will lead the Health Data Science Centre (previously known as the Centre for Analysis Decisions and Society) of Human Technopole, the institute for life sciences based in Milan. The Centre has been developed in partnership with Politecnico di Milano and it will develop different lines of research, including Applied Health Analytics in collaboration with Politecnico di Milano. The Centre’s mission is dedicated to the analysis and integration of large-scale healthcare data.
Trained in cardiovascular medicine in Italy and France, Emanuele is currently Professor of Clinical Epidemiology at the University of Cambridge. He has made seminal contributions to clinical epidemiology and applied health research, and he is the author of several studies published in leading international scientific journals. In 2020, he was included in the ‘Highly Cited Researchers 2020’ list from Clarivate, which recognises authors of the most influential research papers around the world. Alongside his role at Human Technopole, Emanuele will remain active at the University of Cambridge, helping to establish strategic partnerships between the two Institutions.
Emanuele will lead the Centre with the aim to help deliver a step-change in health data science in Italy, by systematically mobilising and harvesting “big data” allowing an agnostic and dynamic collection of information and delivering a new class of research that will enable to better understand the clinical, molecular, behavioural and environmental determinants of non-communicable diseases for patient and public benefit.
Emanuele Di Angelantonio, Head of the Health Data Science Centre at Human Technopole commented: “Thanks to large-scale data analysis and to the partnership with Politecnico, our Centre will help understanding and, consequently, prevention and treatment of diseases allowing the identification and development of novel and actionable approaches to improve human health. Our aim is to help seek major new clinical insights by enabling innovative integrative studies of electronic health records, imaging, wearable and biomolecular data. The ultimate vision is to create new informatics infrastructures, analytical capabilities, data science methods, and programmes of multidisciplinary research that enable the acceleration of health research in Italy”.
Human Technopole Director Iain Mattaj commented: “With Emanuele’s nomination we have completed Human Technopole’s first-stage scientific leadership. The Centre for Health Data Science reflects our global approach to life sciences which embraces basic research while supporting, through the use of artificial intelligence and big data analysis, the management of public health. These aspects are complementary and functional to Human Technopole’s mission to improve human health and well-being”.
Health Data Science Centre
The Health Data Science Centre aims to become a reference institution for the analysis of healthcare data. It will collect data and information from a variety of sources by establishing a dialogue with regional healthcare districts, hospitals and scientific societies. The Centre will integrate clinical data with socioeconomic and environmental risk factors to identify precise vulnerability profiles in order to create targeted policy interventions. In addition, it will work to develop solutions for the analysis of data, developing and integrating new analytical methods with clinical epidemiology and healthcare research.
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.